Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merlin L Robb

Showing results (271-280 of 358) with videos related to

Pageof 36
Sort By:
The Lancet. HIV|February 10, 2020
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trialPunnee Pitisuttithum, Sorachai Nitayaphan, Suwat Chariyalertsak, et al.
Science Translational Medicine|March 6, 2020
Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infectionLouise Leyre, Eugène Kroon, Claire Vandergeeten, et al.
JCI Insight|March 9, 2018
Fine epitope signature of antibody neutralization breadth at the HIV-1 envelope CD4-binding siteHao D Cheng, Sebastian K Grimm, Morgan Sa Gilman, et al.
Plos One|May 12, 2017
Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative womenPeter B Gilbert, Jean-Louis Excler, Georgia D Tomaras, et al.
AIDS (London, England)|January 3, 2020
Machine-learning classification of neurocognitive performance in children with perinatal HIV initiating de novo antiretroviral therapyRobert H Paul, Kyu S Cho, Andrew C Belden, et al.
The New England Journal of Medicine|May 19, 2016
Prospective Study of Acute HIV-1 Infection in Adults in East Africa and ThailandMerlin L Robb, Leigh A Eller, Hannah Kibuuka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2020
Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency VirusJoanna Hellmuth, Camilla Muccini, Donn J Colby, et al.
Plos Pathogens|December 16, 2014
Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activationAlexandra Schuetz, Claire Deleage, Irini Sereti, et al.
Plos One|January 26, 2013
Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trialSusan Zolla-Pazner, Allan C deCamp, Timothy Cardozo, et al.
The New England Journal of Medicine|April 21, 2021
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19Jerald Sadoff, Glenda Gray, An Vandebosch, et al.
Pageof 36

Showing results (271-280 of 358) with videos related to

Sort By:
Pageof 36
The Lancet. HIV|February 10, 2020
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trialPunnee Pitisuttithum, Sorachai Nitayaphan, Suwat Chariyalertsak, et al.
Science Translational Medicine|March 6, 2020
Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infectionLouise Leyre, Eugène Kroon, Claire Vandergeeten, et al.
JCI Insight|March 9, 2018
Fine epitope signature of antibody neutralization breadth at the HIV-1 envelope CD4-binding siteHao D Cheng, Sebastian K Grimm, Morgan Sa Gilman, et al.
Plos One|May 12, 2017
Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative womenPeter B Gilbert, Jean-Louis Excler, Georgia D Tomaras, et al.
AIDS (London, England)|January 3, 2020
Machine-learning classification of neurocognitive performance in children with perinatal HIV initiating de novo antiretroviral therapyRobert H Paul, Kyu S Cho, Andrew C Belden, et al.
The New England Journal of Medicine|May 19, 2016
Prospective Study of Acute HIV-1 Infection in Adults in East Africa and ThailandMerlin L Robb, Leigh A Eller, Hannah Kibuuka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2020
Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency VirusJoanna Hellmuth, Camilla Muccini, Donn J Colby, et al.
Plos Pathogens|December 16, 2014
Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activationAlexandra Schuetz, Claire Deleage, Irini Sereti, et al.
Plos One|January 26, 2013
Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trialSusan Zolla-Pazner, Allan C deCamp, Timothy Cardozo, et al.
The New England Journal of Medicine|April 21, 2021
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19Jerald Sadoff, Glenda Gray, An Vandebosch, et al.
Pageof 36